EUVIMEDOpdag EUVIMED
Crossref

Preliminary Evidence of GLUT4 Upregulation and Biocompatibility of Syzygium caryophyllatum ‐Derived Silver Nanoparticles in 3T3‐L1 Preadipocytes

Santosh Mallikarjun Bhavi iD, Ramesh Babu Yarajarla iD

Cell Biochemistry and Function · 2026-05 · 44 (5)

DOI: 10.1002/cbf.70236 ↗

At a glance

Journal article in Cell Biochemistry and Function, published online on 2026-05-26. Written by Santosh Mallikarjun Bhavi and 1 co-authors. Institution: Department of Applied Genetics, Drosophila and Nano-Biomedicine Research Laboratory, Karnatak University Dharwad, Dharwad, Karnataka, India. Major MEDLINE topics: Glucose Transporter Type 4, Silver, Syzygium, Metal Nanoparticles. 42 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

AMPK signaling and GLUT4 trafficking are key regulators of cellular glucose handling; however, the effects of biogenic silver nanoparticles (AgNPs) in preadipocyte models remain underexplored. This study characterizes Syzygium caryophyllatum ‐mediated SC‐AgNPs (21.78 nm TEM, λ max 449 nm) in 3T3‐L1 preadipocytes. The identical batch, verified stable by UV–vis and visual inspection, was tested across viability (MTT), ROS (DCFDA), mitochondrial function (TMRE), apoptosis (Annexin V/PI), and AMPK/GLUT4 regulation (endpoint RT‐PCR, Western blot) using vehicle controls. SC‐AgNPs showed high biocompatibility (IC 50 605.8 μg/mL, > 95% viability at 5–50 μg/mL) with modest changes in cellular responses, including controlled ROS elevation (1.3‐fold) and mitochondrial hyperpolarization (2.21‐fold), while apoptosis was observed at IC 50 (91.7%). At sub‐toxic working concentrations, GLUT4 mRNA/protein increased 1.55‐/1.6‐fold (GAPDH/β‐actin normalized), while total AMPK expression decreased (0.2‐ to 0.7‐fold), indicating that the underlying regulatory mechanism remains unclear and requires further investigation. These findings provide preliminary evidence of GLUT4 modulation in 3T3‐L1 preadipocytes under non‐cytotoxic conditions. However, due to the use of undifferentiated cells and the absence of functional assays, these results should be interpreted cautiously and require validation in differentiated and insulin‐resistant adipocyte models.

Subjects

MeSH terms (MEDLINE)

Glucose Transporter Type 4SilverSyzygiumMetal NanoparticlesAdipocytesUp-RegulationBiocompatible MaterialsAnimalsMice3T3-L1 CellsReactive Oxygen SpeciesApoptosisCell SurvivalAMP-Activated Protein Kinases

Author keywords

3T3‐L1AMPKAgNPsGLUT4Syzygium caryophyllatum

Substances

Glucose Transporter Type 4SilverSlc2a4 protein, mouseReactive Oxygen SpeciesBiocompatible MaterialsAMP-Activated Protein Kinases

Authors and institutions

  • Department of Applied Genetics, Drosophila and Nano-Biomedicine Research Laboratory, Karnatak University Dharwad, Dharwad, Karnataka, India.

ORCID profiles: Santosh Mallikarjun Bhavi, Ramesh Babu Yarajarla

Cite

APA

Bhavi, S. M., & Yarajarla, R. B. (2026). Preliminary Evidence of GLUT4 Upregulation and Biocompatibility of Syzygium caryophyllatum ‐Derived Silver Nanoparticles in 3T3‐L1 Preadipocytes. Cell Biochemistry and Function, 44(5). https://doi.org/10.1002/cbf.70236

Vancouver

Bhavi SM, Yarajarla RB. Preliminary Evidence of GLUT4 Upregulation and Biocompatibility of Syzygium caryophyllatum ‐Derived Silver Nanoparticles in 3T3‐L1 Preadipocytes. Cell Biochemistry and Function. 2026;44(5). doi:10.1002/cbf.70236

BibTeX
@article{Bhavi2026,
  author = {Bhavi, Santosh Mallikarjun and Yarajarla, Ramesh Babu},
  title = {Preliminary Evidence of GLUT4 Upregulation and Biocompatibility of Syzygium caryophyllatum ‐Derived Silver Nanoparticles in 3T3‐L1 Preadipocytes},
  journal = {Cell Biochemistry and Function},
  year = {2026},
  volume = {44},
  number = {5},
  doi = {10.1002/cbf.70236}
}
Start for free →